Patents Assigned to Astrazeneca Pharamceuticals LP
  • METHOD FOR TREATING DIABETES WITH EXTENDED RELEASE FORMULATION OF GLP-1 RECEPTOR AGONISTS
    Publication number: 20140220134
    Abstract: The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of pharmaceutical formulations containing a non-aqueous carrier and GLP-1 receptor agonists that provides therapeutically effective plasma concentration levels of the GLP-1 receptor agonists over the course of a month.
    Type: Application
    Filed: June 21, 2012
    Publication date: August 7, 2014
    Applicants: Astrazeneca Pharamceuticals LP, Amylin Pharmaceuticals LLC
    Inventors: Matthew L. Zierhut, Brenda B. Cirincione